Seqirus Pty Ltd
Regulatory activities for this sponsor.
Loading...
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (14)
- Australian Public Assessment Report (AusPAR) (11)
- Prescription medicine evaluation (5)
- Section 14, TGO91 consent (3)
- Prescription medicine decision summary (2)
- Cancellation or suspension (1)
- Designation or determination (1)
Sponsor content
152 result(s) found, displaying 81 to 90
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACARIZAX Standardised allergen extract from American house dust mite extract & European house dust mite extract 12 SQ-HDM sublingual tablet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFLURIA QUAD - Inactivated Quadrivalent Influenza vaccine (split virion), 60 mcg HA, Suspension for injection, pre-filled syringe with attached needle.
-
Designation or determinationPriority review
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Influenza virus haemagglutinin
-
Australian Public Assessment Report (AusPAR)
-
Prescription medicine registrationActive ingredients: safinamide mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack.
-
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer., effective 22/06/2018
-
Prescription medicine registrationActive ingredients: American house dust mite extract, European house dust mite extract.
-
Cancellation by sponsorRequested by Seqirus Pty Ltd